Study to Investigate The Pharmacokinetics of GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers
GL2702 GLARS-NF1 tablet is controlled released formulation which is invented by GL Pharm Tech Corp.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
36
0.4mg once a day
0.4mg once a day
Chonbuk National University Hospital
Jeonju, Jeollabukdo, South Korea
Cmax
Pharmacokinetic parameter of tamsulosin 0.4mg
Time frame: 48 hours
AUClast
Pharmacokinetic parameter of Tamsulosin 0.4mg
Time frame: 48 hours
Tmax
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
t1/2
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
Vz/F
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
CL/F
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.